Bill To Exclude Hemp From The Controlled Substances Act

hempfieldCongressman James Comer (R-KY-1) and 15 co-sponsors have reintroduced legislation to amend the federal Controlled Substances Act to exclude industrial hemp.

Currently, the Controlled Substances Act of 1970 labels hemp as a Schedule I drug.

H.R. 3530 excludes low-THC strains of cannabis grown for industrial purposes from the federal definition of marijuana.

The majority of US states have already enacted legislation redefining hemp as an agricultural commodity and allowing for its cultivation. In 2014, members of Congress approved language in the omnibus federal Farm Bill explicitly authorizing states to sponsor hemp research absent federal reclassification of the plant.

All parts of the hemp plant can be cultivated and used to produce everyday household items. It can be grown as a renewable source for raw materials such as clothing, paper, construction materials, and biofuel. Not only is it useful, but growing hemp is much more environmentally friendly than traditional crops.

According to the Congressional Research Service, the United States is the only developed nation in which industrial hemp is not an established crop.

Click HERE to urge your Representative to support this legislation.

 

Scientists lay the groundwork for a reliable marijuana breathalyzer

An important step has been taken toward a reliable marijuana breathalyzer by measuring the vapor pressure of delta-9 tetrahydrocannabinol (THC) — a measurement that, due to the compound’s chemical structure, is very difficult and has not been accomplished before.

Study: Cannabinoids Reduce Migraine Frequency

mj_researchThe prolonged daily administration of cannabinoids is associated with a reduction in migraine headache frequency, according to clinical trial data presented at the 3rd Congress of the European Academy of Neurology.

Italian researchers compared the efficacy of oral cannabinoid treatments versus amitriptyline – an anti-depressant commonly prescribed for migraines – in 79 chronic migraine patients over a period of three months. Subjects treated daily with a 200mg dose of a combination of THC and CBD achieved a 40 percent reduction in migraine frequency – a result that was similar to the efficacy of amitriptyline therapy.

Subjects also reported that cannabinoid therapy significantly reduced acute migraine pain, but only when taken at doses above 100mg. Oral cannabinoid treatment was less effective among patients suffering from cluster headaches.

“We were able to demonstrate that cannabinoids are an alternative to established treatments in migraine prevention,” researchers concluded.

Some five million Americans are estimated to experience at least one migraine attack per month, and the condition is the 19th leading cause of disability worldwide.

According to retrospective data published last year in the journal Pharmacotherapy, medical cannabis consumption is often associated with a significant decrease in migraine frequency, and may even abort migraine onset in some patients.

A just published review of several studies and case-reports specific to the use of cannabis and cannabinoids in the journal Cannabis and Cannabinoid Research concludes: “[I]t appears likely that cannabis will emerge as a potential treatment for some headache sufferers.”

An abstract of the study, “Cannabinoids suitable for migraine prevention,” appears online here.

Low-dose THC can relieve stress; more does just the opposite

Low levels tetrahydrocannabinol, or THC, the main psychoactive compound in marijuana, does reduce stress, but in a highly dose-dependent manner, new research confirms.

Study: Inhaled Cannabis Controls Tics In Patients With Tourette’s Syndrome

Medical marijuanaInhaled cannabis is effective and well-tolerated in patients with Tourette’s Syndrome, according to clinical data published online ahead of print in the Journal of Neuropsychiatry and Clinical Neuroscience.

A team of researchers at the University of Toronto retrospectively assessed the safety and efficacy of inhaled cannabis in 19 TS patients.

Researchers reported, “All study participants experienced clinically significant symptom relief,” including including reductions in obsessive-compulsive symptoms, impulsivity, anxiety, irritability, and rage outbursts. Eighteen of 19 patients experienced decreased tic severity. Cannabis was “generally well tolerated” by study subjects.

They concluded: “Overall, these study participants experienced substantial improvements in their symptoms. This is particularly striking given that almost all participants had failed at least one anti-tic medication trial. … In conclusion, cannabis seems to be a promising treatment option for tics and associated symptoms.”

Placebo controlled data has previously determined that oral THC dosing also improves tics and obsessive-compulsive behavior in TS patients. However, patients utilizing inhaled cannabis have generally shown greater overall improvement.

An abstract of the study, “Preliminary evidence on cannabis effectiveness and tolerability for adults with Tourette Syndrome,” is online here.

NORML Forms Multi-State Workplace Drug Testing Coalition

mj_salesThe fact that 190 million Americans now live in states where marijuana has been legalized to some degree is raising a number of questions and issues about how to integrate the American workforce and marijuana consumers rights in regards to drug testing. With medical marijuana is legal in 29 states and recreational marijuana for adult use in 8 states and Washington DC, millions of responsible and otherwise law-abiding adults remain at risk of being excluded from the workforce due to a positive drug test — even where the use does not affect an individual’s job performance or has taken place days or weeks prior to the test.

NORML believes that this practice is discriminatory and defies common sense. As a result, a growing coalition of NORML Chapters in California, Oregon, Colorado and Washington have come together to advocate for necessary legislative and workplace reforms to protect responsible marijuana consumers.

NORML’s Workplace Drug Testing Coalition’s efforts will focus on these four areas:

  1. Reform workplace drug testing policies
  2. Expand employment opportunities for marijuana consumers
  3. Clarify the difference between detection technology and performance testing
  4. Highlight off-duty state law legal protections for employees

“Even though marijuana is legal and readily available in several states, consumers are being unfairly forced to choose between their job and consuming off the clock as a result of out-of-date employment practices,” said Kevin Mahmalji, National Outreach Coordinator for NORML. “That is why many NORML chapters active in legal states are now shifting their attention to protecting honest, hardworking marijuana consumers from these sort of antiquated, discriminatory workplace drug-testing practices, in particular the use of random suspicionless urine testing.”

Employer testing of applicants or employees for trace metabolites (inert waste-products) of past use of a legal substance makes no sense in the 21st century.  This activity is particularly discriminatory in the case of marijuana where such metabolites may be detectable for weeks or even months after the consumer has ceased use.

With the 2017 Legislative Session underway, this issue is finally getting the attention it deserves. Legislation has already been introduced in Oregon and Washington, and is gaining traction in those states.

“Random suspicionless drug testing of applicants or employees for past marijuana use is not just unfair and discriminatory, it’s bad for business,” said attorney Judd Golden of Boulder, Colorado, a long-time NORML activist and Coalition spokesperson. The modern workforce includes countless qualified people like Brandon Coats of Colorado, a paraplegic medical marijuana patient who never was impaired on the job and had an unblemished work record. Brandon was fired from a Fortune 500 company after a random drug test, and lost his case in the Colorado Supreme Court in 2015. The Court unfortunately found Colorado’s lawful off-duty activities law that protects employees for legal activities on their own time didn’t apply to marijuana use.

California NORML is also expecting legislation to be introduced this session to address this issue. Ellen Komp, deputy director of California NORML said, “One of the most frequently asked questions we have been getting since Prop. 64 passed legalizing adult marijuana use in California last November is, ‘Am I now protected against drug testing on my job?’ Sadly in our state, not even medical marijuana patients are protected against job discrimination, and it’s a priority of Cal NORML to change that. We are hoping to get a bill introduced at the state level and are working with legislators, unions, and other reform groups to make that happen.”

NORML Chapters across the country are advocating on behalf of the rights of responsible marijuana consumers against discrimination in the workplace. “Our coalition was formed with the intention of not only educating legislators, but also with businesses in mind.  It is important they know testing for marijuana is not mandatory, and that employers have testing options,” said Jordan Person, executive director for Denver NORML. The Denver chapter is currently working with companies that offer performance impairment testing of workers suspected of on-the-job impairment or use rather than unreliable bodily fluid testing to help provide options for employers.

thumbs_upFor decades drug testing companies and others have pushed their agenda through a campaign of misinformation. Until now there has never been an organized effort to challenge the profit- driven ideology of those who seek to benefit from intrusive drug screening. Mounting evidence continues to prove there is no logical reason why adult marijuana consumers should be treated with any less respect, restricted more severely, and denied the same privileges we extend to responsible adults who enjoy a casual cocktail after a long day at the office.

For legal questions, please contact Coalition spokesperson Judd Golden at juddgolden@outlook.com. For other marijuana related questions or an interview, please contact Kevin Mahmalji at kevinm@norml.org.

THC in marijuana makes rats lazy, less willing to try cognitively demanding tasks

New research suggests there may be some truth to the belief that marijuana use causes laziness — at least in rats.

Illinois: Governor Signs Marijuana Decriminalization Measure

thumbs_upRepublican Governor Bruce Rauner signed legislation today amending the state’s marijuana possession penalties.

Senate Bill 2228 reduces the penalties for the possession of up to 10 grams of marijuana from a criminal misdemeanor (formerly punishable by up to six months in jail and a $1,500 fine) to a civil fine of no more than $200 — no arrest and no criminal record.

It also decriminalizes related offenses involving the possession of marijuana paraphernalia.

Senate Bill 2228 also amends the state’s zero tolerance per se traffic safety law, stating that the presence of THC in blood at levels below 5ng/ml “shall not give rise to any presumption that the person was or was not under the influence of cannabis.”

The full text of the measure is available here.

According to the ACLU, Illinois police arrest some 50,000 individuals annually for marijuana possession offenses — ranking #5 in the nation in per capita marijuana possession arrests.

Illinois becomes the third largest state to decriminalize minor marijuana possession offenses.

NORML’s Legislative Round Up July 22nd, 2016

take_actionThe DEA announced that they will amend their quotas for 2017 regarding the cultivation of research-grade marijuana and hemp legalization bills in Pennsylvania and Rhode Island have been signed into law! We also have updates from Illinois, Florida, and Ohio. Keep reading to learn the latest in marijuana law reform news from around the country and to find out how you can #TakeAction!

Federal:

In a notice published in the Federal Register, Acting DEA Administrator Chuck Rosenberg proposed amending the amount of marijuana that may be produced under federal license in 2017 to approximately 1,041 pounds. The agency alleges that this quantity will be sufficient to provide for the “estimated medical, scientific, research and industrial needs of the United States.”

The US Drug Enforcement Administration is also preparing to respond to an administrative petition calling for the reclassification of marijuana as a schedule I prohibited substance. Their determination was originally expected in the first half of 2016 but it has yet to be released.

State:

Florida: Next Tuesday, the state’s first state-licensed medical marijuana dispensary will open to the public. Trulieve, a licensed cannabis cultivator and distributor, will provide a high CBD, low THC strain of the plant to patients that are registered with the state. However, as of today not a single eligible patient is registered with the state to legally access the product. This is because Florida’s law, initially passed in 2014, is among the strictest in the country. Under the law, patients diagnosed with cancer, seizures, or intractable muscle spasms are eligible for CBD-dominant cannabis, while those diagnosed with a terminal illness are eligible for THC-dominant cannabis. To date, however, only 15 physicians in the state are participating in the program.

Illinois: Two months ago lawmakers voted in favor of Senate Bill 2228, legislation to decriminalize the possession of small amounts of marijuana. But Governor Bruce Rauner has yet to sign the measure into law. The bill makes the possession of up to 10 grams of marijuana a civil violation punishable by a fine of $100-$200 — no arrest and no criminal record. Currently, those caught possessing that amount could face up to six months of jail time and fines of up to $1,500. The bill also amends the state’s zero tolerance per se traffic safety law.

#TakeAction  and contact Governor Rauner to urge him to sign this legislation into law.

Ohio: Governor John Kasich has signed legislation so that certain drug offenses are no longer punishable by a mandatory loss of one’s driver’s license. Under previous law, any drug conviction carried a mandatory driver’s license suspension of at least six months, even in cases where the possession offense did not take place in a vehicle. Senate Bill 204 makes such suspensions discretionary rather than mandatory. The law will take effect September 13th, 2016.

industrial_hempPennsylvania: On Wednesday, July 20th, Governor Tom Wolf signed legislation, House Bill 967, to establish “a pilot program to study the growth, cultivation or marketing of industrial hemp.” The new law took immediate effect. Twenty-eight states have now enacted similar legislation.

Rhode Island: Governor Gina Raimondo has signed legislation, H8232, to establish rules for the commercial, licensed cultivation of hemp in the state. The legislation creates the “Hemp Growth Act” to treat hemp as an agricultural product that may be legally produced, possessed, distributed and commercially traded. The Department of Business Regulation will be responsible for establishing rules and regulations for the licensing and regulation of hemp growers and processors.

Cannabinoids remove plaque-forming Alzheimer’s proteins from brain cells

Scientists have found preliminary evidence that tetrahydrocannabinol (THC) and other compounds found in marijuana can promote the cellular removal of amyloid beta, a toxic protein associated with Alzheimer’s disease.

Danish cannabis is stronger than ever

The concentration of the euphoriant THC in cannabis has tripled in the space of 20 years in Denmark. The reason may be a systematic processing of the cannabis plants, some of which are being grown in skunk farms in Denmark. Cannabis of such high quality can lead to a greater risk of harm and adverse side effects. This is in particular a problem for the large group of young people who smoke it several times a month.

Group wants medical marijuana legalized – Florida

A Florida woman is pushing for the legalization of medical marijuana — trying to get 700000 people across the state to sign a petition to get the proposed constitutional amendment on next year’s ballot.
Video Rating: 5 / 5

Transcription to follow: The Medical Marijuana the government supplies four of us today, has been grown at the University of Mississippi in Oxford since the ’70′s. It grows every year I guess. And they ship it to North Carolina and they get it rolled into papers, and then they look like a Pall Mall, I wish I had one now, but I am leaving tomorrow and all of those are gone. All I have in there now is my utencils and things like that. They don’t smell like marijuana sometimes, I don’t know. This new batch I can’t wait to get back home and really pay more attention because I automatically just took them out of the thing to make my oils, so I could bake with it and stuff because I have to concentrate because of the low THC. It didn’t dawn on me till after I was doing my little capsules, I’m looking at it, hey wait a minute, I haven’t had to clean this, this is clean. Oh my god, what is this, then I read, oh this is from last year. Wow that is awesome. That’s great. So I am looking forward to humidifying it, which you always have to do, because it is freeze-dried and then rerolling it and smoking it, or vaporizing it. I will definitely be doing both when I get home. I have to carry my cannabis with me, because I don’t want that suitcase to get lost with 6 tins a 6 month supply of marijuana for me. So what happens is, I just put it in my back pack, and my purse. I carry it with me all the time. And always wonder what craziness is gonna happen next. But I carry a little card

Medical Cannabis, Past & Future, with Michael Aldrich, PhD

April 5.2008 – After Fifth Clinical Conference on Cannabis Therapeutics, held in Pacific Grove, CAMichael Aldrich, PhD, looks back to 1964, tracing the roots of the “marijuana movement” in America and Dr. Raphael Mechoulam’s isolation of THC in Israel. Citing new science and research since the “discovery” of the Endo-Cannabinoid System in 1989 and it’s role throughout the body, Dr. Aldrich examines medical Cannabis in the 21st century, anticipating many aspects and applications of this remarkable plant. Conference hosted by Patients Out of Time. DVDs are available. medicalcannabis.com

Could the chemicals found in marijuana prevent and even heal several deadly cancers? Discover the truth about this ancient medicine as world-renowned scientists in the field of cannabinoid research illustrate their truly mind-blowing discoveries. “What if Cannabis Cured Cancer” explains how we are all born with a form of marijuana already in our bodies, and when pot is consumed, the “endocannabinoids” inside us, along with any cannabinoids we ingest, fit together like a key in a lock. Thereby promoting the death of cancer cells without harming the body’s healthy cells. A powerful and eye-opening film about the future of cannabis, and perhaps even the future of medicine. Narrated by Emmy-winning actor Peter Coyote. QUOTES: “What If Cannabis Cured Cancer summarizes the remarkable research findings of recent years about the cancer-protective effects of novel compounds in marijuana. Most medical doctors are not aware of this information and its implications for prevention and treatment. This documentary presents compelling evidence that our current policy on cannabis is counterproductive and foolish. An excellent film.” -Andrew Weil, MD *** “A hugely important film.” -Julie Holland, MD NYU School of Medicine *** “What If Cannabis Cured Cancer brings to light a host of recent findings that have potentially game-changing implications for the future of marijuana as a medicine. A must-see film.” -Marijuana Policy Project Washington, DC *** SPECIAL BONUS: Comedy puppet short
Video Rating: 4 / 5

BRKDWN – Medical Marijuana to treat Kids: I know my THC’s

Mikayla Comstock is a seven year old girl living in Oregon who is going through chemotherapy. Her mom is giving her THC treatments to ease her pain. Is this better than traditional medications? Subscribe! Though protested by Mikayla’s Father and various doctors, Mikayla’s THC treatment is endorsed by her own mother and Dr. Sanjay Gupta. Is this safer than the more common medications given for paitients? Is it safe for kids? Cynthia and Jon BRK it DWN. Sources: bit.ly Video sources: Friday (movie) – Twinny twin twin – Twenty twen twen – bit.ly David After Dentist – bit.ly Katt Williams “It’s Just A Plant!” – bit.ly Japanese McDonalds SpongeBob Comercial HD – bit.ly Follow us on Twitter: @BRK_DWN Like us on Facebook: Facebook.com/BRKDWN
Video Rating: 4 / 5

Chronic Medical Cannabis Use by US Legal Patients, Part 1

Even as the federal government calls for more research into medical marijuana, it has refused to study it’s own patients, who receive monthly shipments of Cannabis though the IND(Investigational New Drug Program). One patient, appearing at the 2002 Clinical Conference on Cannabis Therapeutics where this series was presented, had received 300 “joints” per month for 20 years. Quantifiable and assayed for THC, the government-grown marijuana is low quality, but has suceeded in treating the conditions for which it was prescribed, with little apparent harmful effects. Patients Out of Time, hosts of the conference, knew this opportunity for good science shouldn’t be missed, so it enlisted the help of doctors and researchers to perform physical and pyschological tests on four of the legal patients: Elvy Musikka; Irvin Rosenfeld; George McMahon and a MS patient. Dr. Ethan Russo, co-ordinator of the study, first presents patient demographics; medical conditions; and dosage levels, then lists tests performed, including: MRI scans; chest x-rays and pulminory function tests; neuro-pychological exams; endocrine and immune system tests. The entire one hour presentation from which Part 1 is edited can be viewed at: video.google.com including the “Beck Depression Inventory”, which showed a remarkable lack of clinical depression in the legal marijuana patients(considering their serious medical conditions),as Dr. Russo challenges the “attitude among gov’t officials that euphoria is a bad

Login | Register

Copyright Top Nug © All Rights Reserved · Top Nug Theme by Ame

PIXSELL8 Pixel Count Remaining